Meixi Peng

1.1k total citations
26 papers, 702 citations indexed

About

Meixi Peng is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Meixi Peng has authored 26 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Cancer Research and 6 papers in Epidemiology. Recurrent topics in Meixi Peng's work include Cancer, Hypoxia, and Metabolism (7 papers), Epigenetics and DNA Methylation (5 papers) and Autophagy in Disease and Therapy (5 papers). Meixi Peng is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Epigenetics and DNA Methylation (5 papers) and Autophagy in Disease and Therapy (5 papers). Meixi Peng collaborates with scholars based in China, United States and Saudi Arabia. Meixi Peng's co-authors include Manran Liu, Yixuan Hou, Xiaojiang Cui, Huan Zeng, Xueying Wan, Yilu Qin, Shuiqing Liu, Lei Xi, Maojia Zhao and Jun Ren and has published in prestigious journals such as The FASEB Journal, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Meixi Peng

23 papers receiving 699 citations

Peers

Meixi Peng
Avital Gaziel‐Sovran United States
Nobuhiko Sugito Japan
Mellissa J. Nixon United States
Alf Spitschak Germany
Melissa M. Wolf United States
Chuanhe Yang United States
Sylvia Mahara Singapore
Ming Quan China
Sergey Karakashev United States
Shaokun Shu China
Avital Gaziel‐Sovran United States
Meixi Peng
Citations per year, relative to Meixi Peng Meixi Peng (= 1×) peers Avital Gaziel‐Sovran

Countries citing papers authored by Meixi Peng

Since Specialization
Citations

This map shows the geographic impact of Meixi Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meixi Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meixi Peng more than expected).

Fields of papers citing papers by Meixi Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meixi Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meixi Peng. The network helps show where Meixi Peng may publish in the future.

Co-authorship network of co-authors of Meixi Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Meixi Peng. A scholar is included among the top collaborators of Meixi Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meixi Peng. Meixi Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Meixi, Yongxiu Huang, Zhengyu Chen, et al.. (2025). New insights into extracellular vesicles in metastatic cancer: From mechanisms to diagnostics and targeted therapies. Molecular Therapy. 33(10). 4731–4747.
2.
Li, Lulu, et al.. (2025). The role of phosphatidylcholine metabolism in tumors. Medical Oncology. 42(10). 450–450.
3.
Peng, Meixi, Zhenyu Wang, Yongxiu Huang, et al.. (2024). A novel LGALS1-depended and immune-associated fatty acid metabolism risk model in acute myeloid leukemia stem cells. Cell Death and Disease. 15(7). 482–482. 7 indexed citations
4.
Peng, Meixi, Xiaoqiang Zeng, Jiawei Xu, et al.. (2024). Microenvironmental G protein‐coupled estrogen receptor‐mediated glutamine metabolic coupling between cancer‐associated fibroblasts and triple‐negative breast cancer cells governs tumour progression. Clinical and Translational Medicine. 14(12). e70131–e70131. 6 indexed citations
5.
Liu, Xiaoqi, Xueying Wan, Ming Xu, et al.. (2023). Oxidized ATM governs stemness of breast cancer stem cell through regulating ubiquitylation and acetylation switch. Biochemical and Biophysical Research Communications. 691. 149243–149243. 2 indexed citations
6.
Huang, Yongxiu, et al.. (2023). LAPTM4B promotes AML progression through regulating RPS9/STAT3 axis. Cellular Signalling. 106. 110623–110623. 2 indexed citations
7.
Huang, Junpeng, Ming‐Hui Sun, Jun Ren, et al.. (2023). Cytoplasmic Expression of TP53INP2 Modulated by Demethylase FTO and Mutant NPM1 Promotes Autophagy in Leukemia Cells. International Journal of Molecular Sciences. 24(2). 1624–1624. 18 indexed citations
8.
Ren, Jun, Meixi Peng, Yipei Jing, et al.. (2022). Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia. Cell Death and Disease. 13(10). 915–915. 18 indexed citations
9.
Li, Lei, Jun Ren, Meixi Peng, et al.. (2022). Mutant NPM1-Regulated FTO-Mediated m6A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis. Frontiers in Oncology. 12. 817584–817584. 20 indexed citations
10.
Peng, Meixi, et al.. (2022). Targeting Mitochondrial Oxidative Phosphorylation Eradicates Acute Myeloid Leukemic Stem Cells. Frontiers in Oncology. 12. 899502–899502. 16 indexed citations
11.
Peng, Meixi, Jun Ren, Yipei Jing, et al.. (2022). Circulating plasma exosomal long non-coding RNAs LINC00265, LINC00467, UCA1, and SNHG1 as biomarkers for diagnosis and treatment monitoring of acute myeloid leukemia. Frontiers in Oncology. 12. 1033143–1033143. 27 indexed citations
12.
Jing, Yipei, Meixi Peng, Jun Ren, et al.. (2021). Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3. Journal of Experimental & Clinical Cancer Research. 40(1). 312–312. 36 indexed citations
13.
Qiu, Yuan, Jianping Xiong, Qin Fu, et al.. (2021). GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma. Frontiers in Oncology. 11. 638171–638171. 16 indexed citations
14.
Xi, Lei, Meixi Peng, Shuiqing Liu, et al.. (2021). Hypoxia‐stimulated ATM activation regulates autophagy‐associated exosome release from cancer‐associated fibroblasts to promote cancer cell invasion. Journal of Extracellular Vesicles. 10(11). e12146–e12146. 98 indexed citations
15.
Qin, Yilu, Yixuan Hou, Shuiqing Liu, et al.. (2020). A Novel Long Non‐Coding RNA lnc030 Maintains Breast Cancer Stem Cell Stemness by Stabilizing SQLE mRNA and Increasing Cholesterol Synthesis. Advanced Science. 8(2). 2002232–2002232. 77 indexed citations
16.
Zhao, Maojia, Yixuan Hou, Liping Yang, et al.. (2020). Drosha-independent miR-6778–5p strengthens gastric cancer stem cell stemness via regulation of cytosolic one-carbon folate metabolism. Cancer Letters. 478. 8–21. 29 indexed citations
17.
Yang, Dan, Meixi Peng, Yixuan Hou, et al.. (2020). Oxidized ATM promotes breast cancer stem cell enrichment through energy metabolism reprogram-mediated acetyl-CoA accumulation. Cell Death and Disease. 11(7). 508–508. 29 indexed citations
18.
Yu, Tenghua, Hong Cheng, Zhiliang Wang, et al.. (2020). GPER mediates decreased chemosensitivity via regulation of ABCG2 expression and localization in tamoxifen-resistant breast cancer cells. Molecular and Cellular Endocrinology. 506. 110762–110762. 32 indexed citations
19.
Sun, Kexin, Shifu Tang, Yixuan Hou, et al.. (2019). Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling. EBioMedicine. 41. 370–383. 104 indexed citations
20.
Lang, Lei, Yixuan Hou, Yanlin Chen, et al.. (2018). ATM-Mediated Phosphorylation of Cortactin Involved in Actin Polymerization Promotes Breast Cancer Cells Migration and Invasion. Cellular Physiology and Biochemistry. 51(6). 2972–2988. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Avital Gaziel‐Sovran Breakdown of academic impact, for papers by Nobuhiko Sugito Breakdown of academic impact, for papers by Mellissa J. Nixon Breakdown of academic impact, for papers by Alf Spitschak Breakdown of academic impact, for papers by Melissa M. Wolf Breakdown of academic impact, for papers by Chuanhe Yang Breakdown of academic impact, for papers by Sylvia Mahara Breakdown of academic impact, for papers by Ming Quan Breakdown of academic impact, for papers by Sergey Karakashev Breakdown of academic impact, for papers by Shaokun Shu
Rankless by CCL
2026